What’s Happening

Dr. Schlegel Delivers the “Life of Learning” Address at Georgetown’s 2020 Fall Faculty Convocation (21:30-35:37)

Dr. Jeffrey Huang Talks Remyelination Strategies in Multiple Sclerosis

Living Biobanks News

Conditional Reprogramming of Urine Cultures for Bladder Cancer
An Interview with Dr. Xuefeng Liu 

MS research scientist Dr. Jeffrey Huang is this year’s recipient of the Harry Weaver Neuroscience Scholar Award from the National MS Society. On this edition of the “Real Talk MS” podcast, Dr. Huang talks about his potentially groundbreaking research, as well as how one becomes an MS research scientist.

Employing “living biobanks” to advance biomedical research –   A group of seasoned experts from the International Society for Biological and Environmental Repositories explain the notion of employing “living biobanks” to advance the field of biomedical research

Jeff Huang Data photo

Congratulations to Dr. Jeff Huang for his win with the National Multiple Sclerosis Society and the Harry Weaver Neuroscience Scholar Awards! 

Doctor’s Speak Out Series: Schlegel Shares Updates on Preventing and Treating Cervical Cancer

National Cancer Institute: Human Papillomavirus | Did You Know?

November 2017
Did you know that infection with about a dozen HPV types is associated with cancer among both men and women? Watch the HPV Did You Know? video to learn about the types of cancers caused by HPV, incidence rates in the U.S., HPV vaccination, and screening. For more statistics on HPV, visit cancer.gov’s HPV Fact Sheet. Help raise awareness about HPV by sharing this video with friends, family, and your social media networks. Help raise awareness about HPV!  

Georgetown Researchers Describe Method to Study Real Time Cancer Invasion

November 2016
Dr. Anton Wellstein is co-senior investigator of a study at Georgetown Lombardi Comprehensive Cancer Center in which a team is studying the steps that allow cancer investigators to track cancer cell invations and metastasis in transparent zebrafish embryos…in real time. Their hopes are that answers will be found to cancer questions in a shorter amount of time and advance the understanding of cancer biology and experimental drug testing.

National Academy of Inventors: Clinical Translation of HPV and Cell Culture Research Presentation

April 28, 2015
Dr. Richard Schlegel was invited to present at the 2015 National Academy of Inventors’ Annual Conference earlier this year. Dr. Schlegel spoke about the clinical translations of HPV and cell culture research.

Continuing Research with CRCs and HPV Education

July 9, 2015
Dr. Richard Schlegel’s continual effort on conditionally reprogrammed cells (CRCs) has helped Dr. Sherrie Wallington, of Georgetown’s Lombardi Comprehensive Cancer Center, with her endeavors of educating the Washington D.C. community on the effects of HPV and the benefits of its vaccine.

Research & Innovation at Georgetown University Medical Center

August 14, 2014
Dr. Richard Schlegel was recently featured in Georgetown University Medical Center’s video about groundbreaking research and how it is affecting lives within and outside the GUMC community.  

John Carroll Awards 2011

April 30, 2011
Dr. Richard Schlegel is honored with The Patrick Healy Award presented by the Alumni Association at Georgetown University for his research, which led to the first cancer vaccine, and his future efforts in cell immortalization.